Axis-Shield : AFINION HbA1c patent granted in USA

27 June, 2008: Axis-Shield (LSE:ASD, OSE:ASD), the international in-vitro diagnostics company, announces that it has received notice of approval of its US patent application governing the measuring methodology for HbA1c within the Afinion™ cassette for detection of this important marker of diabetic patient compliance. The patent protects technology which improves HbA1c stability, precision and accuracy and has resulted in a longer product shelf-life with improved performance. The invention may also have utility for the well-established NycoCard™ product for the same marker... Axis-Shield's Press Release -